BioTech Gilead Sciences, Inc. (GILD)’s HCV Cure Will Continue to get Paid by Insurers: CramerBy Tim FrederickAugust 21, 2014 Gilead Sciences, Inc.(NASDAQ:GILD) came under the spotlight of Jim Cramer’s Stop Trading segment today on CNBC, and the investor showed…
BioTech Why Gilead Sciences, Inc. (GILD) Is Not Rising Despite Blowout Quarter: Meg TirrellBy Solon Harmony B. DolorJuly 24, 2014 Gilead Sciences, Inc. (NASDAQ:GILD) is not trending up in the stock market even though they have reported impressive numbers, Meg…